FDA to PTO

 Here. 

Competition Law and the Pharmaceutical Sector in India

S. Mondal and V. Pingali, here. 

Patent Trolling — Why Bio & Pharmaceuticals are at Risk

R. Feldman, W.Nicholson Price II, here.

When Competition Law Analysis Goes Wrong – The Italian Pfizer/Pharmacia Case

D. Geradin, here.

Patients’ Needs, Medicines Innovation and the Global Public’s Interests

M. Lundeby-Grepstad, D.Tordrup, T. Craig and D. Taylor, here.

Indian government refutes Novartis' allegations of 'discriminatory' patent practices

Economictimes.indiatimes.com, here. 

Pfizer's slams India's patent regime, says Indian standards are vague and malleable

Economictimes.indiatimes.com, here. 

India’s Patently Wise Decision

J. Stiglitz, A. Jayadev, here. 

AU Government launches review of pharmaceutical patents

Ipaustralia.gov.au, here.